Skip to content

Author

H. Khalifa

We have 7 of 99 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Combating colistin- and cefotaxime-resistant Shiga toxin-producing Escherichia coli in dairy-based products: Occurrence, characterization, and ε-poly-L-lysine growth inactivation.

Continuous monitoring of foodborne pathogens, especially multidrug-resistant (MDR) bacteria, is crucial for the food industry, healthcare, and regulatory agencies. This study assessed the prevalence, antimicrobial resistance, and virulence genes (stx1, stx2, and eaeA) in Escherichia coli strains isolated from milk and...

Mahmoud Elafify, H. Khalifa, Qi-Sen Xiang et al. · 0 citations
Open access Sep 2026

First report of carbapenemase-producing bacteria from poultry farms in the United Arab Emirates: an emerging One Health threat

Carbapenemase-producing bacteria represent a critical global public health threat, yet their presence and molecular characteristics in food animal production systems remain poorly understood. This study provides the first comprehensive report of carbapenemase-producing bacteria isolated from poultry farms in the Un...

H. Khalifa, Temesgen Mohammed, Mushal Allam et al. · 0 citations
Review Open access Sep 2026

Bridging the gap between experimental evidence and clinical applications of antipseudomonal phage therapy against Pseudomonas aeruginosa.

Pseudomonas aeruginosa is one of the World Health Organization's (WHO) priority pathogens requiring urgent intervention because of its remarkable ability to develop antimicrobial resistance. The rapid emergence and global dissemination of multidrug-resistant P. aeruginosa have made the treatment of these infections inc...

Ahmed Elfadadny, W. Nageeb, Rokaia F. Ragab et al. · 0 citations
Review Open access Aug 2026

Aucubin as a multifunctional iridoid glycoside: Molecular pharmacology and therapeutic mechanisms supporting its potential as a drug discovery scaffold.

This review positions aucubin as a biologically informative iridoid glycoside with substantial scaffold-level relevance for future natural-product-inspired therapeutic development, rather than as a near-term clinical drug candidate.

M. Arafat, Mostafa K. Mohammad, Kareem A. Attallah et al. · 0 citations
Review Open access Aug 2026

Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral disturbance, largely associated with amyloid-β accumulation, tau protein pathology, synaptic dysfunction, oxidative stress and neuroinflammation. Previous research emphasizes the critical...

A. Shaheen, Mou-Sa A. Mai, Merhan O. Hindam et al. · 2 citations
Open access Jul 2026

Kinetic study of glyphosate biodegradation by actinobacterial consortium RH1: implications for bioremediation

The RH1 actinobacterial consortium efficiently degraded glyphosate, fitting best to the Haldane–Andrews kinetic model, highlighting RH1’s potential for bioremediation of glyphosate-contaminated soils.

Hadjer Rebai, Rym Salah-Tazdaït, Djaber Tazdaït et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.